Summit Therapeutics Inc (SMMT)

Jun 25, 2026

Summit Therapeutics Inc Actuals & Estimates (BMV:SMMT) - TradingView

Jun 25, 2026

Jun 24, 2026

SMMT Stock Plunges On Wider Q1 Loss, Lung Cancer Clinical Trial Update - Stocktwits

Jun 24, 2026

Jun 23, 2026

Summit Therapeutics finance chief tops list of public CFO pay in 2025 - CFO.com

Jun 23, 2026

Jun 22, 2026

Bernstein raises Summit Therapeutics stock price target on trial outlook By Investing.com - Investing.com Australia

Jun 22, 2026

Jun 22, 2026

Bernstein raises Summit Therapeutics stock price target on trial outlook - Investing.com

Jun 22, 2026

Jun 22, 2026

Summit Therapeutics (SMMT): A $500 Million Stock Offering Pulled Just One Day After Filing - Insider Monkey

Jun 22, 2026

Jun 22, 2026

Summit Therapeutics: High-Volatility, Catalyst-Driven Binary Bet (NASDAQ:SMMT) - Seeking Alpha

Jun 22, 2026

Jun 22, 2026

Bernstein Maintains Summit Therapeutics(SMMT.US) With Sell Rating, Raises Target Price to $9.8 - Moomoo

Jun 22, 2026

Jun 21, 2026

Why is SMMT stock tumbling today? - MSN

Jun 21, 2026

Jun 20, 2026

5 Most Promising Healthcare Stocks According to Wall Street Analysts - Insider Monkey

Jun 20, 2026

Jun 20, 2026

SMMT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 20, 2026

Jun 19, 2026

Avoiding Lag: Real-Time Signals in (SMMT) Movement - Stock Traders Daily

Jun 19, 2026

Jun 19, 2026

Why Is SMMT Stock Tumbling Today? - Stocktwits

Jun 19, 2026

Jun 19, 2026

Summit rebounds after nearly $50M insider purchase - MSN

Jun 19, 2026

Jun 19, 2026

Summit Therapeutics Inc (SMMT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 19, 2026

Jun 18, 2026

SMMT News | SUMMIT THERAPEUTICS INC (NASDAQ:SMMT) - ChartMill

Jun 18, 2026

Jun 17, 2026

Summit Therapeutics Inc (SMMT) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Summit Therapeutics Inc (SMMT) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 17, 2026

Summit Therapeutics Inc (SMMT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Summit Therapeutics Inc (SMMT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 17, 2026

Summit Therapeutics Inc (SMMT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Summit Therapeutics Inc (SMMT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Summit Therapeutics Inc (SMMT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 16, 2026

Why Summit Therapeutics Is Staying In The Biotechnology Spotlight? - Kalkine Media

Jun 16, 2026

Jun 16, 2026

Should Summit Therapeutics’ Canceled US$500 Million Equity Offering Reshape SMMT Investors’ View on Financing Strategy? - Sahm

Jun 16, 2026

Jun 15, 2026

Summit Therapeutics: Getting A Foot In The Door Isn't Getting Through It (NASDAQ:SMMT) - Seeking Alpha

Jun 15, 2026

Jun 15, 2026

Summit Therapeutics Inc. (SMMT) Investor Outlook: Evaluating A Potential 103.85% Upside - DirectorsTalk Interviews

Jun 15, 2026

Jun 14, 2026

Summit Therapeutics Raises $500 Million in Public Offering to Support Lung Cancer PipelineGAAP Earnings Report - newsline.com

Jun 14, 2026

Jun 14, 2026

SMMT Jumps As Summit Therapeutics Rides Ivonescimab Momentum - timothysykes.com

Jun 14, 2026

Jun 13, 2026

Summit Therapeutics stockholders approve directors and incentive plan - The Globe and Mail

Jun 13, 2026

Jun 13, 2026

Summit Therapeutics (SMMT) Raises $500 Million Through Public Offering - Insider Monkey

Jun 13, 2026

Jun 13, 2026

Insider Buying: Summit Therapeutics Co-CEO, President & Director Bought US$1.5m Of Shares - simplywall.st

Jun 13, 2026

Jun 13, 2026

Summit Therapeutics files for $500M common stock offering; shares slide over 9% - MSN

Jun 13, 2026

Jun 12, 2026

Summit Therapeutics (SMMT) Surges 7% as Bulls Test Key ResistanceRelative Volume - newsline.com

Jun 12, 2026

Jun 12, 2026

Summit Therapeutics (SMMT) Shares Rebound After Co-CEO's $50M St - GuruFocus

Jun 12, 2026

Jun 12, 2026

5 Best Buy-the-Dip Stocks to Invest In Now - Insider Monkey

Jun 12, 2026

Jun 12, 2026

SMMT Jumps As Ivonescimab Trial Success Fuels Financing Drive - StocksToTrade

Jun 12, 2026

Jun 12, 2026

Summit Therapeutics (NASDAQ: SMMT) investors approve directors and 8M-share incentive plan boost - Stock Titan

Jun 12, 2026

Jun 12, 2026

Summit Therapeutics co-CEO Zanganeh acquires $49.98m in shares By Investing.com - Investing.com Australia

Jun 12, 2026

Jun 12, 2026

Summit Therapeutics(SMMT.US) 10% Shareholder Buys US$49.99 Million in Common Stock - Moomoo

Jun 12, 2026

Jun 12, 2026

Insider Stock Purchases: June 12, 2026 - Quiver Quantitative

Jun 12, 2026

Jun 12, 2026

Summit Therapeutics co-CEO Zanganeh acquires $49.98m in shares - Investing.com

Jun 12, 2026

Jun 12, 2026

Co-CEO Mahkam Zanganeh (SMMT) reports spouse’s 3.81M-share open-market buy - Stock Titan

Jun 12, 2026

Jun 12, 2026

Summit Therapeutics (SMMT) Shares Rebound After Co-CEO's $50M Stock Purchase - GuruFocus

Jun 12, 2026

Jun 12, 2026

Summit Therapeutics (SMMT) Gains 2.83% as Stock Approaches Key Resistance LevelLow Beta Factor - newsline.com

Jun 12, 2026

Jun 12, 2026

Summit gains after nearly $50M insider buy (SMMT:NASDAQ) - Seeking Alpha

Jun 12, 2026